continu coverag co buy rate
tp unchang deriv target price base
non-gaap ep respect
assum forward earn multipl
provid upsid potenti
continu good perform total sale rose
driven broad base organ growth doubl
digit increas ep strong organ growth across
geograph area consid number expect
growth better
three busi segment group safeti graphic
deliv anoth outstand quarter organ growth
person safeti busi grew doubl digit health care
continu expend world-wide organ growth
segment also report posit growth
perform geograph perspect robust
compani continu capit opportun develop
market second quarter asia pacif
deliv organ growth led health safeti
graphic organ growth china hong
kong india japan
 organ growth led electron
energi safeti graphic consum emea increas
driven strong growth west europ led
electron industri safeti graphic
latin america canada growth increas led
health safeti graphic countri level canada
high singl digit mexico brazil
compani companytickermmmstock ratingbuyunchangedindustri viewoverweightpositivepric jul week week volum volum ep margin margin ttm per share growth profit ttm ttm incom ttm earn growth co juli
incom statement
result overview
non-
product perform develop
valuat consensu perform
overal deliv strong growth quarter led
increas growth rate across segment
geographi go forward continu execut
strengthen market posit well prepar
deliv strong result beyond
revenu quarter increas
y/i compar organ sale
quarter increas increas sell
price contribut basi point sale growth
acquisit net divestitur increas
foreign currenc translat increas sale y/i
month perform revenu six
month perform end june
increas compar
driven higher organ sale increas sell
price busi transform posit
impact product effort
six month period repurchas
billion worth common stock paid dividend worth
million
remain unchang rang full year
adjust ep rang versu
prior rang updat rang
reflect impact divest incom associ
commun market busi foreign currenc
translat add full year sale growth versu
prior expect
averag price-to-earnings current price-to-earnings around
higher
perform strong expect forward earn
multipl
stock price histori date high obsolet date obsolet move move share statist averag volum averag volum share held held share short short share short prior month error dividend split forward annual dividend forward annual dividend trail annual dividend trail annual dividend year averag dividend pay-out dividend date jun ex-dividend date may last split factor new per last split date sep inform co juli
incom statement
result overview
non-
product perform develop
valuat consensu perform
non- reconcili refer
 market account total prepaid current total current build machineri furnitur total fix non-curr defer incom non-curr total non-curr total equiti liabilitiesaccount accru defer current liabilities- total current long-term defer incom non-curr minor interest total non-curr total prefer stock equity- common stock addit paid-in retain treasuri total total total liabil stock actual annual balanc sheet itemsactu quarterli
cash-flow oper activ six month period decreas million billion
due minnesota nrd resolut addit factor decreas oper cash flow
ncreas inventori account receiv
inflow invest activ million increas million due sale
substanti commun market divis sale certain person safeti product
offer primarili focus nois environment
six month period repurchas billion worth common stock paid
dividend worth million
depreciation- amortization- defer incom oper increas decreas increas decreas current assets- decreas increas decreas increas current liabilities- decreas increas work capital- non- net continu net discontinu operations- net total oper invest activitiessal properti plant purchas properti plant net invest financ activitiesissu issuanc capit repurchas capit payment financ charg discontinu financ activities- net financ net floweffect exchang rate net chang begin end co juli
revenu
quarter
increas y/i
driven higher organ
group geograph
diversifi global manufactur technolog innov compani
report result revenu growth strong driven higher organ
growth across busi group geograph area
revenu quarter increas y/i
compar organ sale quarter increas
increas sell price contribut basi point sale
growth acquisit net divestitur increas foreign currenc
translat increas sale y/i
geograph basi total sale grew emea asia pacif
 latin america/canada organ local currenc
sale increas latin america/canada emea
asia pacif
cog quarter
increas
due foreign currenc
charg increas
cog quarter increas
increas due foreign currenc effect suppli chain footprint
optim charg increas sell price y/i
partial off-set higher defin benefit pension post retir servic
cost expens gross margin percentag revenu increas
sg expens quarter increas
due restructur charg relat address corpor
function cost commun market divis divestitur
oper incom
decreas
due higher
postretir
 expens declin
continu invest key initi includ innov program
potenti creat entir new market disrupt exist market
oper incom
oper margin stood compar oper
margin posit affect organ local currenc growth product
addit lower y/i portfolio suppli chain footprint charg
net incom
quarter
increas
benefit per share
relat divestitur
commun
revenu six
end june
driven higher organ
sale increas
net incom six
month period
gaap ep
effect tax rate quarter decreas
increas tax rate due impact minnesota
measur period adjust relat tcja
net incom quarter increas compar
ep quarter increas
compar compani record benefit per share
relat divestitur commun market busi
revenu six month perform end june
increas compar driven
higher organ sale increas sell price busi transform
posit impact product effort
cog six month period increas
due foreign currenc effect portfolio suppli chain footprint
optim charg increas sell price
sg expens increas compar
higher increas sg expens six month period due
impact charg relat minnesota nrd resolut
partial off-set portfolio suppli chain footprint optim charg
repeat
net incom six month period
ep
exclud first quarter pre tax impact relat resolut
minnesota natur resourc damag matter measur
period adjust relat tcja ep increas
result overview geograph area
million
world
world
sale
asia pacif region six month period sale increas
compar asia pacif geograph area
china/hong kong total sale increas organ sale increas
japan total sale increas driven foreign currenc translat
impact organ sale decreas exclud electron japan
total sale increas organ local-curr sale increas
emea region overal sale grew compar
emea region central/east europ east/africa
total organ sale increas west europ total sale grew
driven foreign currenc translat impact organ local-
currenc sale increas
latin america/canada geograph region overal sale grew
compar latin america/canada
geograph area total sale grew mexico organ sale increas
canada total sale increas driven organ sale growth
addit foreign currenc translat impact brazil total sale
decreas organ sale growth off-set
oper five report busi segment includ industri
safeti graphic healthcar electron consum
revenu contribut busi segment
highest revenu
quarter
sale industri
quarter
industri growth
broad base across
oper incom
led
organ sale growth
sale industri quarter
organ basi sale increas industri growth
broad base across geograph area industri growth also led
advanc materi abras separ purif busi
high singl digit growth quarter
geograph basi industri organ growth led increas
emea follow mid-single-digit growth area
oper incom led
organ sale growth geograph area
changenet month end mn three month graphicshealth careelectron energyconsumercorpor unallocatedelimin dual credit co juli
sale industri
six month period
end june
posit impact
sale industri six month period end june
foreign currenc
posit impact
organ sale industri segment increas due growth
separ purif automot aerospac advanc materi
oper incom six month period increas
due organ sale growth across portfolio
sale safeti
quarter
strong growth across
busi
oper incom
declin
due y/i impact
safeti graphic busi
mn
sale safeti graphic busi segment quarter
organ basi sale increas
strong growth across busi led person safeti
solut also transport safeti roof granul
geograph basi organ growth led growth emea high
singl digit increas asia-pacif latin america canada
grew organ quarter
oper incom declin
relat y/i impact divestitur gain
safeti graphic busi
sale safeti
busi six
june
increas
sale six month period end june increas
sale acquisit increas
divestitur reduc sale foreign currenc posit impact
organ sale safeti busi segment increas led person
safeti commerci solut roof granul
oper incom six month period decreas
due y/i impact divestitur gain
sale care
segment
quarter
basi sale increas
mn
oper incom
due impact
legal settlement
new clariti
sale care segment quarter
organ basi sale increas health
care medic solut busi grew mid singl digit second quarter oral
care continu growth intern market
geograph basi asia-pacif latin america high singl digit
emea grew follow continu strength
develop market led china hong kong
oper incom due
impact legal settlement commerci invest new clariti
sale health care
segment six
month increas
sale six month period end june increas
foreign currenc posit impact
organ sale increas led growth food safeti health medic
solut oral care grew geograph region particularli develop
countri howev sale declin drug deliveri system
oper incom six month period increas
sale electron
segment
quarter
led
growth electron
oper incom
driven commun
electron energi
mn
sale electron segment quarter
organ basi sale increas led
growth electron busi due increas electron materi
solut also sale increas display materi system
geograph basi led high single-digit organ growth follow
mid-single-digit growth emea asia-pacif latin america canada
low singl digit
oper incom driven
sale electron
six month period
increas
sale consum
busi segment
quarter
oper incom
due benefit
expens relat
electron energi
sale six month period increas
foreign currenc posit impact partial off-set
divestitur reduc sale
organ sale increas led growth electron materi solut
partial off-set declin display market system due soft
oper incom six month period increas
driven commun market divis divestitur
mn
sale consum busi segment quarter
organ basi sale increas led
higher growth home busi grew doubl digit due strong
geograph basi led high single-digit organ growth follow
mid-single-digit growth latin america canada second quarter
strong consum demand product particularli
oper incom due
benefit expens relat portfolio footprint action taken
second quarter repeat second quarter
sale six month period increas
foreign currenc posit impact
organ sale increas led growth home improv home
care stationari offic suppli deliveri
oper incom six month period increas due
benefit expens relat portfolio
sale consum
segment six
oper incom
increas
due benefit
expens relat
bn except ep
incom tax
provis incom tax
organ growth expect remain unchang rang
full year adjust ep rang versu prior rang
updat rang reflect impact divest incom
associ commun market busi
foreign currenc translat add full year sale growth versu prior
expect
diversifi global manufactur technolog innov market wide
rang product servic perform time high quarterli revenu
mainli due growth organ local currenc sale growth
busi group across geograph area
perform well quarter full year robust organ growth
across busi group geograph area safeti graphic deliv anoth
outstand quarter organ growth safeti busi grew doubl
digit healthcar continu expend world-wide organ growth
segment also report posit growth quarter
continu invest innov technolog help compani increas
growth rate across segment geographi go forward continu execut
strengthen market posit well prepar deliv strong result
beyond
roe roa net margin ttm basi
non- reconcili
non- reconcili
non- reconcili
incom statement
result overview
non-
product perform develop
valuat consensu perform
gross margin ttm basi end decemb gross margin
cog
net margin compar end decemb indic healthi margin tax rate
return asset ttm basi return equiti
cap ex percentag sale stood free cash flows/sal
revenu grew y/i oper margin declin net margin increas
ratio revenu margin margin inc margin rate margin turnov averag asset leverag averag equiti year averag averag averag year averag averag averag year averag averag averag growth growth ex sale /sale /net incom ratio profit marginsprofitabilityrevenu growth oper incom growthep growth co juli
mrqgross mrqoper mrqnet mrqcog mrqsg mrqr sale growth ratio
inv flow sale
mrqyoy growth revenu growthoper incom growthep mrq ratio growth yoy oper growth yoy free growth mrqcapex salescap ex salesfre mrqfinanci mrqreturn mrqreturn equiti price-to-earnings
histor trade higher bound lower bound
aug valuat broke upper band almost reach valuat due
strong perform organ sale
averag price-to-earnings current price-to-earnings around higher
perform strong expect forward earn multipl
per share item ratio
fiscal per per per per share flow per per valu per book per end stock end stock equiti asset invest capit capit joel greenblatt margin margin margin equiti total debt total pay-out sale account convers rate incom incom margin itemsquarterli item balanc sheet item
outstand equival market properti plant properti plant issuanc prefer issuanc chang co juli
incom statement
result overview
non-
product perform develop
valuat consensu perform
breakdown share held insid share held institut mutual fund float held institut mutual fund institut hold direct holder form reportedthulin ing hak michael juli nichola institut holdersholdersharesd report outvaluevanguard group inc massachusett servic state mutual automobil insur america fmr northern trust well fargo geod capit manag top mutual fund holdersholdersharesd report outvaluevanguard total stock market vanguard spdr etf spdr jone industri averag vanguard institut fund-institut vanguard specialized-dividend appreci mf seri trust i-mf valu fidel contrafund ishar vanguard growth competit
usda food safeti inspect servic choos coli salmonella listeria testingjuli food safeti award contract depart agricultur food safeti inspect servic usda fsi pathogen detect instrument kit award make molecular detect primari method use usda fsi detect ofsalmonella listeria monocytogen coli includ three major pathogen organ threaten safeti meat poultri egg-rel product system chosen rigor perform evalu commerci avail method molecular detect combin novel technolog isotherm dna amplif bioluminesc detect result fast accur easy-to-us applic overcom limit pcr polymeras chain reaction pathogen test smog-reduc granul har power sun improv qualityjun industri miner product divis recent launch smog-reduc granul help remov smog pollut nitrogen oxid nox use roof shingl integr throughout shingl surfac roof granul design special photocatalyt coat appli base miner special coat granul activ sun uv ray blend inconspicu variou shingl color combin sunlight hit shingl contain smog-reduc granul radic gener transform nitrogen oxid gase water-solubl ion improv air qualiti smart solut pollut mitig help commun contribut toward noxemiss reduct lead way roof technolog solut improv environment impact human health welfar said frank klink senior laboratori manag roof granul first residenti asphalt shingl new granul help roof manufactur develop high qualiti aesthetically-pleas shingl turn roof activ smog reduc catalyst essenti becom smog worst introduc elast blend nonwoven tape improv conform skin breathabilityjun expand line-up advanc adhes medic devic addit singl coat medic extend wear adhes nonwoven tape pressur sensit adhes offer omni-direct stretch superior conform breathabl thin water-resist tape offer excel initi skin adhes wear time well improv conform long wear time compar tape product line filtret brand amazon integr new filtret smart filter amazon dash replenishmentapril smart filter first-ev bluetooth-en hvac air filter home integr amazon dash replenish automat reorder air filter need replac filtret smart filter avail purchas particip retail nationwid co juli
incom statement
result overview
non-
product perform develop
valuat consensu perform
sale growth past
compar
gross margin ttm
basi
roa roi roe
ttm basi
respect
actual vs price-to-earnings ratio ttm price-to-earnings high last yr price-to-earnings last yr beta price sale ttm price book mrq price ttm price free ttm errorerrorerror own dividend yield dividend yield year average dividend year growth rate pay-out ratio ttm sale mrq vs qtr yr sale ttm vs ttm yr sale yr growth rate sale yr growth rate ep mrq vs qtr yr ep ttm vs ttm yr ep yr growth rate ep yr growth rate capit spend yr growth rate lt debt equiti mrq total debt equiti mrq interest coverag ttm gross margin ttm gross margin yr average ebitd margin ttm ebitd yr average oper margin ttm oper margin yr average pre-tax margin ttm pre-tax margin yr average net profit margin ttm net profit margin yr average effect tax rate ttm effect tax rate yr average return asset ttm return asset yr average return invest ttm return invest yr average return equiti ttm return equiti yr average revenue/employe ttm net income/employe ttm receiv turnov ttm inventori turnov ttm asset turnov ttm manag effect effici performancevalu ratio dividend growth rate ratio profit consensu view analyst trend stock
rate expect
growth rate expect
forward price-to-earnings
compar
annual usdgrowth high day day day estim comparisonmmmindustri avg avgprice/earn yield avgfive-year growth forecast consensu view analyst trend stock
estim revenu growth
 respect
consensu ep trend estim
adjust ep estim
 respect
estimatescurr analyst estimatethi estim estimatepast ep growthprice/earningsobsoleteobsoleteobsoleteobsoletepeg ratioobsoleteobsoleteobsoleteobsoleteconsensu ep day day day day ep last last last dayserrorerrorerrorerrordown last dayscurr surprisescurr growth rate co juli
incom statement
result overview
non-
product perform develop
valuat consensu perform
past month stock volatil stock price increas less howev post
result juli stock price rose level rang
stock look posit shown continu increas trend last year went upto
howev mid jan stock price start revers fell till level last one year
stock given moder return
week high low
stock given total return last year
mmm top-lin continu increas healthi pace given revenu perform
maintain stock buy rate target price estim stock
price base forward price-to-earnings ep
crispidea financi inform servic firm focus provid equiti research portfolio manag
person wealth manag brokerag servic inform servic side provid commun
consult research servic host client
crispidea track limit number compani sector strive provid qualiti insight straight
forward analysi object creat long-term wealth moder low risk crispidea leverag
larg number in-hous extern expert oper within industri strong financi oper
strateg background
detail visit www crispidea com contact
